Bridgebio Oncology Therapeutics, Inc. (BBOT)
8.91
0.00 (0.00%)
USD |
NASDAQ |
Apr 06, 16:00
8.87
-0.04
(-0.45%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics EPS Diluted (Quarterly) : -0.485 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| EyePoint Plc | -0.8143 |
| Praxis Precision Medicines, Inc. | -3.500 |
| Rapport Therapeutics, Inc. | -0.7187 |
| Olema Pharmaceuticals, Inc. | -0.5044 |
| Arcellx, Inc. | -1.003 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.80M |
| Total Expenses (Quarterly) | 38.80M |
| Enterprise Value | 290.40M |
| Earnings Yield | -16.86% |
| Normalized Earnings Yield | -16.86 |